987-P: Efficacy and Safety Comparison between U-100 Human Regular Insulin and Rapid-Acting Insulin When Delivered by V-Go Wearable Insulin Delivery in an Older Type 2 Diabetes Population.

Autor: SUTTON, DAVID R., MORA, PABLO F., GORE, ASHWINI, BALIGA, BANTWAL, GOLDFADEN, REBECCA F., NIKKEL, CARLA C., SINK II, JOHN H., ADAMS-HUET, BEVERLEY A.

Publikováno v: Diabetes; 2020 Supplement, Vol. 69, pN.PAG-N.PAG, 1p

Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis.

Autor: Hundal R; First State Endocrinology, Newark, DE, USA., Kowalyk S; Endocrinology Specialists PC, Greensburg, PA, USA., Wakim A; Center of Endocrinology, Wheeling Hospital, Wheeling, WV, USA., Nikkel C; Medical Affairs, Zealand Pharma, Boston, MA, USA., Sink Ii JH; Medical Affairs, Zealand Pharma, Boston, MA, USA., Doyle M; Progressive Diabetes Care, PLLC, Erwin, NC, USA.

Publikováno v: Medical devices (Auckland, N.Z.) [Med Devices (Auckl)] 2020 Sep 22; Vol. 13, pp. 283-291. Date of Electronic Publication: 2020 Sep 22 (Print Publication: 2020).